Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a Phase I/II study in breast cancer patients
Authors:
- J.P. PerkinsJPJ.P. Perkins
- J.W. HiemenzJHJ.W. Hiemenz
- P.E. ZorskyPZP.E. Zorsky
- W.E. JanssenWJW.E. Janssen
- L.E. KronishLKL.E. Kronish
- M.C. MachakMMM.C. Machak
- G.J. ElfenbeinGEG.J. Elfenbein
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in Surgical Oncology
- Vol. 2 (1) , 87-95
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Ifosfamide, carboplatin, and etoposide in combination for induction and high‐dose chemotherapy: focus on breast cancer and lymphomaHematological Oncology, 1992
- A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.Journal of Clinical Oncology, 1990
- High-dose ifosfamide with mesna uroprotection: a phase I study.Journal of Clinical Oncology, 1990
- A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support.Journal of Clinical Oncology, 1989
- High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.Journal of Clinical Oncology, 1988
- Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985
- Ifosfamide-pharmacology, safety and therapeutic potentialCancer Treatment Reviews, 1985
- Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP updateCancer, 1983
- High-dose ifosfamide and mesna as continuous infusion over five days—a phase I/II trialCancer Treatment Reviews, 1983
- Phase II study of VP16-213 (Etoposide) in refractory metastatic breast carcinomaCancer Chemotherapy and Pharmacology, 1982